Mailing a simple information pamphlet to interested drinkers in the general population reduced binge drinking by 10 per cent, and is a promising public health approach to reduce the health and social problems associated with heavy drinking, shows a new study led by the University of Alberta.
Novartis has received a positive opinion supporting European U nion approval of its cell culture-derived seasonal influenza vaccine Optaflu?, which is aiming to become the first influenza vaccine to utilize a mammalian cell line, rather than chicken eggs, for antigen production.
Solvay announced that its dossier for intravenous tedisamil (intended brand name: PULZIUM? IV), a new chemical entity coming from Solvay Pharmaceuticals R&D laboratories, has been filed for approval by the US Food and Drug Administration (FDA) as well as by the authorities of European U nion countries.
Abbott announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), granted a positive opinion recommending approval of HUMIRA? (adalimumab) for the treatment of severe Crohn’s disease.
Though preventable and treatable, malaria claims the lives of more than 1 million people each year ? 75 percent of them African children.
Biomedical researchers have identified a cellular protein that interferes with hepatitis C virus replication, a finding that ultimately may help scientists develop new drugs to fight the virus.
Every year, at least 200 000 people die from cancer related to their workplace, according to the World Health Organization (WHO). Saturday is World Day for Safety and Health at Work.
An anti-reflux valve developed to help esophageal cancer patients also has been shown to help those with bile duct obstruction, according to Kulwinder S. Dua, M.D., a research physician at the Medical College of Wisconsin in Milwaukee.
The amount Americans spent on arthritis medications more than doubled between 1998 and 2003, due to the fast-rising number of people with the disease, increases in the number of medications they take each month and the inflation-adjusted cost per prescription, according to a new study led by a UCSF researcher.
A new study shows that aspirin therapy for coronary artery disease is four times more likely to be ineffective in women compared to men with the same medical history.